These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
610 related articles for article (PubMed ID: 10931025)
1. Prognosis and surgical management of patients with palpable inguinal lymph node metastases from melanoma. Hughes TM; A'Hern RP; Thomas JM Br J Surg; 2000 Jul; 87(7):892-901. PubMed ID: 10931025 [TBL] [Abstract][Full Text] [Related]
2. Combined inguinal and pelvic lymph node dissection for stage III melanoma. Hughes TM; Thomas JM Br J Surg; 1999 Dec; 86(12):1493-8. PubMed ID: 10594495 [TBL] [Abstract][Full Text] [Related]
3. Ilioinguinal lymph node dissection for palpable metastatic melanoma to the groin. Allan CP; Hayes AJ; Thomas JM ANZ J Surg; 2008 Nov; 78(11):982-6. PubMed ID: 18959697 [TBL] [Abstract][Full Text] [Related]
4. The analysis of the outcomes and factors related to iliac-obturator involvement in cutaneous melanoma patients after lymph node dissection due to positive sentinel lymph node biopsy or clinically detected inguinal metastases. Zdzienicki M; Rutkowski P; Nowecki ZI; van Akkooi AC; Michej W; Dziewirski W; Świtaj T; Pieńkowski A; Sałamacha M; Bylina E; Eggermont AM Eur J Surg Oncol; 2013 Mar; 39(3):304-10. PubMed ID: 23298828 [TBL] [Abstract][Full Text] [Related]
5. The survival benefit to patients with positive sentinel node melanoma after completion lymph node dissection may be limited to the subgroup with a primary lesion Breslow thickness greater than 1.0 and less than or equal to 4 mm (pT2-pT3). Nowecki ZI; Rutkowski P; Michej W Ann Surg Oncol; 2008 Aug; 15(8):2223-34. PubMed ID: 18506535 [TBL] [Abstract][Full Text] [Related]
6. Pelvic lymph node dissection is beneficial in subsets of patients with node-positive melanoma. Badgwell B; Xing Y; Gershenwald JE; Lee JE; Mansfield PF; Ross MI; Cormier JN Ann Surg Oncol; 2007 Oct; 14(10):2867-75. PubMed ID: 17671814 [TBL] [Abstract][Full Text] [Related]
7. Sentinel lymph node biopsy in melanoma: a micromorphometric study relating to prognosis and completion lymph node dissection. Debarbieux S; Duru G; Dalle S; Béatrix O; Balme B; Thomas L Br J Dermatol; 2007 Jul; 157(1):58-67. PubMed ID: 17501957 [TBL] [Abstract][Full Text] [Related]
8. Outcomes of routine ilioinguinal lymph node dissection for palpable inguinal melanoma nodal metastasis. Glover AR; Allan CP; Wilkinson MJ; Strauss DC; Thomas JM; Hayes AJ Br J Surg; 2014 Jun; 101(7):811-9. PubMed ID: 24752717 [TBL] [Abstract][Full Text] [Related]
9. [Surgical technique and postoperative morbidity following radical inguinal/iliacal lymph node dissection--a prospective study in 67 patients with malignant melanoma metastatic to the groin]. Mall JW; Reetz C; Koplin G; Schäfer-Hesterberg G; Voit C; Neuss H Zentralbl Chir; 2009 Sep; 134(5):437-42. PubMed ID: 19757344 [TBL] [Abstract][Full Text] [Related]
10. Multivariable analysis comparing outcome after sentinel node biopsy or therapeutic lymph node dissection in patients with melanoma. van Akkooi AC; Bouwhuis MG; de Wilt JH; Kliffen M; Schmitz PI; Eggermont AM Br J Surg; 2007 Oct; 94(10):1293-9. PubMed ID: 17702089 [TBL] [Abstract][Full Text] [Related]
11. The benefits of adjuvant radiation therapy after therapeutic lymphadenectomy for clinically advanced, high-risk, lymph node-metastatic melanoma. Agrawal S; Kane JM; Guadagnolo BA; Kraybill WG; Ballo MT Cancer; 2009 Dec; 115(24):5836-44. PubMed ID: 19701906 [TBL] [Abstract][Full Text] [Related]
12. Inguinal node dissection for melanoma in the era of sentinel lymph node biopsy. Sabel MS; Griffith KA; Arora A; Shargorodsky J; Blazer DG; Rees R; Wong SL; Cimmino VM; Chang AE Surgery; 2007 Jun; 141(6):728-35. PubMed ID: 17560249 [TBL] [Abstract][Full Text] [Related]
13. Molecular and biochemical testing in stage III melanoma: multimarker reverse transcriptase-polymerase chain reaction assay of lymph fluid after lymph node dissection and preoperative serum lactate dehydrogenase level. Nowecki ZI; Rutkowski P; Kulik J; Siedlecki JA; Ruka W Br J Dermatol; 2008 Sep; 159(3):597-605. PubMed ID: 18616789 [TBL] [Abstract][Full Text] [Related]
15. Morbidity and recurrence after completion lymph node dissection following sentinel lymph node biopsy in cutaneous malignant melanoma. Guggenheim MM; Hug U; Jung FJ; Rousson V; Aust MC; Calcagni M; Künzi W; Giovanoli P Ann Surg; 2008 Apr; 247(4):687-93. PubMed ID: 18362633 [TBL] [Abstract][Full Text] [Related]
16. Elective, therapeutic, and delayed lymph node dissection for malignant melanoma of the head and neck: analysis of 1444 patients from 1970 to 1998. Fisher SR Laryngoscope; 2002 Jan; 112(1):99-110. PubMed ID: 11802046 [TBL] [Abstract][Full Text] [Related]
17. Prognosis in patients with sentinel node-positive melanoma without immediate completion lymph node dissection. van der Ploeg AP; van Akkooi AC; Rutkowski P; Cook M; Nieweg OE; Rossi CR; Testori A; Suciu S; Verhoef C; Eggermont AM; Br J Surg; 2012 Oct; 99(10):1396-405. PubMed ID: 22961519 [TBL] [Abstract][Full Text] [Related]
18. Early (sentinel lymph node biopsy-guided) versus delayed lymphadenectomy in melanoma patients with lymph node metastases : personal experience and literature meta-analysis. Pasquali S; Mocellin S; Campana LG; Bonandini E; Montesco MC; Tregnaghi A; Del Fiore P; Nitti D; Rossi CR Cancer; 2010 Mar; 116(5):1201-9. PubMed ID: 20066719 [TBL] [Abstract][Full Text] [Related]
19. A critical assessment of adjuvant radiotherapy for inguinal lymph node metastases from melanoma. Ballo MT; Zagars GK; Gershenwald JE; Lee JE; Mansfield PF; Kim KB; Camacho LH; Hwu P; Ross MI Ann Surg Oncol; 2004 Dec; 11(12):1079-84. PubMed ID: 15576833 [TBL] [Abstract][Full Text] [Related]
20. Survival analysis and clinicopathological factors associated with false-negative sentinel lymph node biopsy findings in patients with cutaneous melanoma. Nowecki ZI; Rutkowski P; Nasierowska-Guttmejer A; Ruka W Ann Surg Oncol; 2006 Dec; 13(12):1655-63. PubMed ID: 17016755 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]